Lakefront Biotherapeutics NV (LKFT) income statement
LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 7/30
$34.07−0.32 (-0.93%)
Close on Nov 18, 2026Market cap $2.25BP/E 6.3Yield –
Lakefront Biotherapeutics NV income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- 97.3%
- Operating margin
- 26.5%
- Net margin
- 28.9%
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 20.15
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 57.5%
Valuation
- P/E ratio
- 6.3
- Price to sales
- 1.83
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?